Eisai to Launch Rapid-acting Insulin Secretagogue Glufast(R) in China - MarketWatch (press release)
Posted by admin / Under Diabetic Neuropathy
Eisai to Launch Rapid-acting Insulin Secretagogue Glufast(R) in China MarketWatch (press release) Eisai has focused its efforts in China on the development of the peripheral neuropathy treatment Methycobal(R) and other diabetes treatments such as -Lipon ... |
Published on Friday 3rd of September 2010 09:22:31 AM





Share this!